| Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus H Yan, G Zhong, G Xu, W He, Z Jing, Z Gao, Y Huang, Y Qi, B Peng, ... elife 1, e00049, 2012 | 2293 | 2012 |
| Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide H Yan, B Peng, Y Liu, G Xu, W He, B Ren, Z Jing, J Sui, W Li Journal of virology 88 (6), 3273-3284, 2014 | 289 | 2014 |
| Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense X Wang, Y Li, S Liu, X Yu, L Li, C Shi, W He, J Li, L Xu, Z Hu, L Yu, Z Yang, ... Proceedings of the National Academy of Sciences 111 (43), 15438-15443, 2014 | 222 | 2014 |
| Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide H Yan, B Peng, W He, G Zhong, Y Qi, B Ren, Z Gao, Z Jing, M Song, G Xu, ... Journal of virology 87 (14), 7977-7991, 2013 | 216 | 2013 |
| DNA polymerase κ is a key cellular factor for the formation of covalently closed circular DNA of hepatitis B virus Y Qi, Z Gao, G Xu, B Peng, C Liu, H Yan, Q Yao, G Sun, Y Liu, D Tang, ... PLoS pathogens 12 (10), e1005893, 2016 | 203 | 2016 |
| The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement BD Quinlan, H Mou, L Zhang, Y Guo, W He, A Ojha, MS Parcells, G Luo, ... Biorxiv, 2020.04. 10.036418, 2020 | 148 | 2020 |
| Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide W He, B Ren, F Mao, Z Jing, Y Li, Y Liu, B Peng, H Yan, Y Qi, Y Sun, ... PLoS pathogens 11 (4), e1004840, 2015 | 128 | 2015 |
| A potent human neutralizing antibody Fc-dependently reduces established HBV infections D Li, W He, X Liu, S Zheng, Y Qi, H Li, F Mao, J Liu, Y Sun, L Pan, K Du, ... Elife 6, e26738, 2017 | 108 | 2017 |
| Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes G Zhong, H Yan, H Wang, W He, Z Jing, Y Qi, L Fu, Z Gao, Y Huang, G Xu, ... Journal of virology 87 (12), 7176-7184, 2013 | 83 | 2013 |
| A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo G Zhong, H Wang, W He, Y Li, H Mou, ZJ Tickner, MH Tran, T Ou, Y Yin, ... Nature biotechnology 38 (2), 169-175, 2020 | 73 | 2020 |
| Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo W He, Z Cao, F Mao, B Ren, Y Li, D Li, H Li, B Peng, H Yan, Y Qi, Y Sun, ... Journal of virology 90 (19), 8866-8874, 2016 | 51 | 2016 |
| Silencing retinoid X receptor alpha expression enhances early-stage hepatitis B virus infection in cell cultures M Song, Y Sun, J Tian, W He, G Xu, Z Jing, W Li Journal of virology 92 (8), 10.1128/jvi. 01771-17, 2018 | 41 | 2018 |
| Increased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency F Mao, T Liu, X Hou, H Zhao, W He, C Li, Z Jing, J Sui, F Wang, X Liu, ... Journal of Biological Chemistry 294 (31), 11853-11862, 2019 | 32 | 2019 |
| microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture G Xu, Z Gao, W He, Y Ma, X Feng, T Cai, F Lu, L Liu, W Li Virology 448, 247-254, 2014 | 25 | 2014 |
| Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability L Zhang, KR More, A Ojha, CB Jackson, BD Quinlan, H Li, W He, ... npj Vaccines 8 (1), 156, 2023 | 23 | 2023 |
| A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020 MH Tran, H Park, CL Nobles, P Karunadharma, L Pan, G Zhong, H Wang, ... Molecular Therapy-Nucleic Acids 24, 40-53, 2021 | 23 | 2021 |
| An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines Y Guo, W He, H Mou, L Zhang, J Chang, S Peng, A Ojha, R Tavora, ... Mbio 12 (3), 10.1128/mbio. 00930-21, 2021 | 19 | 2021 |
| Potent and specific inhibition of NTCP-mediated HBV/HDV infection and substrate transporting by a novel, oral-available cyclosporine A analogue Y Liu, H Ruan, Y Li, G Sun, X Liu, W He, F Mao, M He, L Yan, G Zhong, ... Journal of medicinal chemistry 64 (1), 543-565, 2020 | 17 | 2020 |
| Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire T Ou, W He, BD Quinlan, Y Guo, MH Tran, P Karunadharma, H Park, ... Molecular Therapy 30 (1), 184-197, 2022 | 10 | 2022 |
| NTCP Deficiency causes gallbladder abnormalities in mice and human beings F Mao, MX Wang, X Hou, Z Zhou, YY Yan, LJ Fang, Z Tan, WY Fang, T Liu, ... Cellular and Molecular Gastroenterology and Hepatology 11 (3), 831-839, 2021 | 10 | 2021 |
Wenhui LiNational Institute of Biological Sciences,BeijingVerified email at nibs.ac.cn
